logo

For the Inventor, By the Inventor

Milwaukee, WI, United States of America

Owen W Griffith

USPTO Granted Patents = 42


Average Co-Inventor Count = 1.7

ph-index = 12

Forward Citations = 512(Granted Patents)


Location History:

  • New York, NY (US) (1988 - 1996)
  • Milwaukee, WI (US) (1994 - 2006)

Company Filing History:

goldMedal24 out of 1,521 
 
Cornell Research Foundation Inc.
 patents
silverMedal9 out of 181 
 
The Medical College of Wisconsin, Inc.
 patents
bronzeMedal7 out of 5,445 
 
University of Texas System
 patents
4. 5 out of 2,008 
 
Duke University
 patents
5. 1 out of 8,370 
 
Massachusetts Institute of Technology
 patents
6. 5 out of 832,718 
Other
 patents
where one patent can have more than one assignee

Years Active: 1988-2006

Loading Chart...
Loading Chart...
42 patents (USPTO):Explore Patents
1. 7022737 - Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses (2006-04-04),
2. 6617355 - Treating asthma by preventing and/or accomodating S-nitrosothiol breakdown (2003-09-09),
3. 6608110 - Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses (2003-08-19),
4. 6359004 - Manipulating nitrosative stress to upregulate nitrosative stress defenses (2002-03-19),
5. 6231894 - Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase (2001-05-15),
6. 6180824 - Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically, proliferating cells or to upregulate nitrosative stress defenses (2001-01-30),
7. 6127420 - L-N.sup.5 -(1-imino-3-alkenyl) ornithine and related compounds and use (2000-10-03),
8. 6057367 - Manipulating nitrosative stress to kill pathologic microbes, pathologic (2000-05-02),
9. 5776979 - Method of use of cardiotonic drugs and inhibitors of nitric oxide (1998-07-07),
10. 5770623 - Argine antagonists for inhibition of systemic hypotension associated (1998-06-23),
11. 5723448 - Preventing conversion of citrulline to argininosuccinate to limit (1998-03-03),
12. 5695751 - Enhancing delivery of large neutral amino acid drugs (1997-12-09),
13. 5663364 - Heme binding compounds and use thereof (1997-09-02),
14. 5545625 - Preventing conversion of citrulline to argininosuccinate to limit (1996-08-13),
15. 5534545 - Parenteral amino acid formulations for the inhibition of systemic (1996-07-09),

Title: The Innovative Journey of Owen W. Griffith

Introduction: Owen W. Griffith, a pioneering inventor hailing from Milwaukee, WI, has made significant contributions to the world of innovations with his creative mind and dedication to progress.

Latest Patents: Owen W. Griffith's latest patents showcase his forward-thinking approach to problem-solving and technology advancements, positioning him as a key figure in the field of inventions.

Career Highlights: Throughout his illustrious career, Owen W. Griffith has been at the forefront of groundbreaking inventions, with a focus on improving everyday life through his innovative solutions. His work has not only garnered recognition but has also positively impacted numerous industries.

Collaborations: Owen W. Griffith's collaborative efforts with leading experts, researchers, and institutions have been instrumental in bringing his inventions to life. His ability to work effectively in teams has led to the successful development and implementation of cutting-edge technologies.

Conclusion: In conclusion, Owen W. Griffith's passion for innovation, coupled with his relentless drive to push boundaries, has solidified his position as a respected inventor in Milwaukee, WI, and beyond. His remarkable journey continues to inspire future generations of inventors to think outside the box and create a better tomorrow.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…